Quoin Pharmaceuticals, Ltd.
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
QNRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74907L1026 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 23 HATA'AS STREET, 44425 KFAR SABA
- Website:
- https://quoinpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Quoin Pharmaceuticals, Ltd. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company is advancing its lead product candidate, QRX003, through pivotal clinical studies for the treatment of Netherton Syndrome. Quoin Pharmaceuticals employs a patient-centric business strategy, aiming to ensure global access to its therapies. This is supported by exclusive international marketing and distribution partnerships covering approximately 60 countries, which augment its planned commercial infrastructure for the United States, Europe, and Japan.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Quoin Pharmaceuticals, Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Quoin Pharmaceuticals, Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Quoin Pharmaceuticals, Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
